[Intraosseous XXXX of the jaw: report of 11 consecutive cases].

@entity1 @entity3 @entity5 @entity808
OBJECTIVE: This study retrospectively analyzed the clinical data of 11 @entity1 with intraosseous @entity808 of the jaw, with the purpose of improve its diagnosis and treatment. METHODS: 11 @entity1 with intraosseous @entity808 of the jaw treated from January 1993 to February 2002 were reviewed, including the clinical features, pathological findings, immunohistochemical findings, imaging examinations and treatment methods. 8 @entity1 with benign lesions were treated with radical curettage and cautery. 2 @entity1 with mandibular malignant lesions were treated with extended resection and neck dissection. 1 @entity1 with @entity5 concomitant with neurofibrostosis was treated with extensive resection and middle split skin graft and neck dissection, followed by chemotherapy and radiotherapy after surgery. RESULTS: The lesions were located in the maxilla in 5 @entity1 (1 was malignant). 6 @entity1 had mandibular lesions (2 were malignant). The X ray findings had some specificity. 10 @entity1 were followed up for 7 to 122 months without recurrence. 1 @entity1 with @entity5 died of multiple @entity3 11 months after treatment. CONCLUSIONS: Intraosseous @entity808 of the jaw was rarely seen clinically. CT, MRI and fine needle aspiration biopsy were beneficial for early diagnosis. Surgery is still the dominant choice of treatment. The prognosis of the @entity1 was generally good. Adjuvant radiotherapy or chemotherapy had limited value, especially for @entity1 with neurofibrostosis. A novel regime called CYVADICDE was recently invoked much clinical interest.
